These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 26612244)
21. The impact of rheumatoid arthritis on the burden of disease in urban China. Langley PC; Mu R; Wu M; Dong P; Tang B J Med Econ; 2011; 14(6):709-19. PubMed ID: 21899486 [TBL] [Abstract][Full Text] [Related]
22. The indirect costs of arthritis resulting from unemployment, reduced performance, and occupational changes while at work. Li X; Gignac MA; Anis AH Med Care; 2006 Apr; 44(4):304-10. PubMed ID: 16565630 [TBL] [Abstract][Full Text] [Related]
23. Economic impact of adalimumab treatment in Japanese patients with rheumatoid arthritis from the adalimumab non-interventional trial for up-verified effects and utility (ANOUVEAU) study. Tanaka Y; Yamazaki K; Nakajima R; Komatsu S; Igarashi A; Tango T; Takeuchi T Mod Rheumatol; 2018 Jan; 28(1):39-47. PubMed ID: 28704126 [TBL] [Abstract][Full Text] [Related]
24. Productivity loss due to presenteeism among patients with arthritis: estimates from 4 instruments. Zhang W; Gignac MA; Beaton D; Tang K; Anis AH; J Rheumatol; 2010 Sep; 37(9):1805-14. PubMed ID: 20595270 [TBL] [Abstract][Full Text] [Related]
25. Productivity Losses Due to Migraine in Slovenia: An Analysis of Absenteeism and Presenteeism Costs Based on Administrative and Self-Reported Data. Lotrič Dolinar A; Žvan B; Došenović Bonča P Zdr Varst; 2020 Jun; 59(2):75-82. PubMed ID: 32952706 [TBL] [Abstract][Full Text] [Related]
26. The economic burden of rheumatoid arthritis: beyond health care costs. Zhang W; Anis AH Clin Rheumatol; 2011 Mar; 30 Suppl 1():S25-32. PubMed ID: 21360103 [TBL] [Abstract][Full Text] [Related]
27. Presenteeism--unhealthy extra presence in the workplace. Zakrzewska K Przegl Epidemiol; 2014; 68(1):77-80, 157-9. PubMed ID: 25004636 [TBL] [Abstract][Full Text] [Related]
28. Burden of rheumatoid arthritis on patients' work productivity and quality of life. Xavier RM; Zerbini CAF; Pollak DF; Morales-Torres JLA; Chalem P; Restrepo JFM; Duhau JA; Amado JR; Abello M; de la Vega MC; Dávila AP; Biegun PM; Arruda MS; Ramos-Remus C Adv Rheumatol; 2019 Nov; 59(1):47. PubMed ID: 31706348 [TBL] [Abstract][Full Text] [Related]
29. Cost of lost productivity in inflammatory arthritis and osteoarthritis in the year before and after diagnosis: An inception cohort study. Xiang L; Graves N; Low AHL; Leung YY; Fong W; Gan WH; Gandhi M; Thumboo J Int J Rheum Dis; 2024 Jul; 27(7):e15252. PubMed ID: 38982887 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of work disability in Japanese patients with rheumatoid arthritis: from the TOMORROW study. Anno S; Sugioka Y; Inui K; Tada M; Okano T; Mamoto K; Koike T Clin Rheumatol; 2018 Jul; 37(7):1763-1771. PubMed ID: 29525846 [TBL] [Abstract][Full Text] [Related]
31. Estimating the Effect and Economic Impact of Absenteeism, Presenteeism, and Work Environment-Related Problems on Reductions in Productivity from a Managerial Perspective. Strömberg C; Aboagye E; Hagberg J; Bergström G; Lohela-Karlsson M Value Health; 2017 Sep; 20(8):1058-1064. PubMed ID: 28964437 [TBL] [Abstract][Full Text] [Related]
32. Health-Related Quality of Life Impairment and Indirect Cost of Crohn's Disease: A Self-Report Study in Poland. Holko P; Kawalec P; Mossakowska M; Pilc A PLoS One; 2016; 11(12):e0168586. PubMed ID: 27992531 [TBL] [Abstract][Full Text] [Related]
33. Productivity costs among patients with rheumatoid arthritis: the influence of methods and sources to value loss of productivity. Verstappen SM; Boonen A; Verkleij H; Bijlsma JW; Buskens E; Jacobs JW; Ann Rheum Dis; 2005 Dec; 64(12):1754-60. PubMed ID: 15860510 [TBL] [Abstract][Full Text] [Related]
34. The significance of presenteeism for the value of lost production: the case of rheumatoid arthritis. Søgaard R; Sørensen J; Linde L; Hetland ML Clinicoecon Outcomes Res; 2010; 2():105-12. PubMed ID: 21935319 [TBL] [Abstract][Full Text] [Related]
35. Development of a composite questionnaire, the valuation of lost productivity, to value productivity losses: application in rheumatoid arthritis. Zhang W; Bansback N; Boonen A; Severens JL; Anis AH Value Health; 2012 Jan; 15(1):46-54. PubMed ID: 22264971 [TBL] [Abstract][Full Text] [Related]
36. Validity of the work productivity and activity impairment questionnaire--general health version in patients with rheumatoid arthritis. Zhang W; Bansback N; Boonen A; Young A; Singh A; Anis AH Arthritis Res Ther; 2010; 12(5):R177. PubMed ID: 20860837 [TBL] [Abstract][Full Text] [Related]
37. Problems in work participation and resource use should not be underestimated in patients with early spondyloarthritis. van der Weijden MA; Boonen A; van der Horst-Bruinsma IE J Rheumatol; 2014 Dec; 41(12):2413-20. PubMed ID: 25320217 [TBL] [Abstract][Full Text] [Related]
38. Impact of one-year treatment with biotechnological drugs on work ability in patients with rheumatoid arthritis in Italy: a prospective real-life study. Manara M; Caporali R; Lomater C; Gorla R; Fusaro E; Sarzi-Puttini P; Stobbione P; Capri S; Sinigaglia L Clin Exp Rheumatol; 2021; 39(2):263-268. PubMed ID: 32573407 [TBL] [Abstract][Full Text] [Related]
39. Sick leave and work disability in patients with early arthritis. Zirkzee EJ; Sneep AC; de Buck PD; Allaart CF; Peeters AJ; Ronday HK; Westedt ML; le Cessie S; Vliet Vlieland TP Clin Rheumatol; 2008 Jan; 27(1):11-9. PubMed ID: 17492248 [TBL] [Abstract][Full Text] [Related]
40. Improvement in work place and household productivity for patients with early rheumatoid arthritis treated with adalimumab plus methotrexate: work outcomes and their correlations with clinical and radiographic measures from a randomized controlled trial companion study. van Vollenhoven RF; Cifaldi MA; Ray S; Chen N; Weisman MH Arthritis Care Res (Hoboken); 2010 Feb; 62(2):226-34. PubMed ID: 20191522 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]